CEO pay
Pharmaceuticals & Biotechnology
465 public companies. The median chief executive was paid $2.2M; the middle half $1M to $4.9M.
| Company | Chief executive | Total pay | Year |
|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | David Kirn | $2.1M | 2025 |
| 60 DEGREES PHARMACEUTICALS, INC. | Tyrone Miller | $283K | 2025 |
| Aardvark Therapeutics, Inc. | Nelson Sun | $2.5M | 2025 |
| ABBOTT LABORATORIES | Robert B. Ford | $22.6M | 2024 |
| AbCellera Biologics Inc. | Andrew Booth | $3.4M | 2025 |
| Abpro Holdings, Inc. | Ian Chan | $522K | 2024 |
| ACHIEVE LIFE SCIENCES, INC. | Erik Atkisson | $983K | 2025 |
| Aclaris Therapeutics, Inc. | Kevin Balthaser | $1.5M | 2025 |
| Acrivon Therapeutics, Inc. | Peter Blume-Jensen | $2M | 2024 |
| Actinium Pharmaceuticals, Inc. | Steve O'Loughlin | $546K | 2025 |
| ACTUATE THERAPEUTICS, INC. | Daniel M. Schmitt | $5.6M | 2024 |
| Acumen Pharmaceuticals, Inc. | Matthew Zuga | $949K | 2025 |
| Acurx Pharmaceuticals, Inc. | David P. Luci | $729K | 2025 |
| Adaptive Biotechnologies Corp | Kyle Piskel | $3.3M | 2025 |
| ADC Therapeutics SA | Ameet Mallik | $2.5M | 2025 |
| ADIAL PHARMACEUTICALS, INC. | Vinay Shah | $459K | 2025 |
| Adicet Bio, Inc. | Chen Schor | $4.6M | 2024 |
| Aditxt, Inc. | Amro Albanna | $500K | 2024 |
| ADMA BIOLOGICS, INC. | Kaitlin Kestenberg | $3.5M | 2025 |
| AEON Biopharma, Inc. | Robert Bancroft | $554K | 2025 |
| AGENUS INC | Garo H. Armen | $4.1M | 2024 |
| AGIOS PHARMACEUTICALS, INC. | Cecilia Jones | $2.5M | 2025 |
| AIM ImmunoTech Inc. | Robert Dickey IV | $108K | 2025 |
| Akebia Therapeutics, Inc. | John P. Butler | $5.7M | 2025 |
| Alaunos Therapeutics, Inc. | Ferdinand Groenewald | $162K | 2024 |
| Aldeyra Therapeutics, Inc. | Todd C. Brady | $3.9M | 2024 |
| Alector, Inc. | Neil Berkley | $1.1M | 2025 |
| Aligos Therapeutics, Inc. | Lesley Ann Calhoun | $1.6M | 2025 |
| Alkermes plc. | Blair C. Jackson | $4M | 2025 |
| Allarity Therapeutics, Inc. | Steen Knudsen | $237K | 2025 |
| ALNYLAM PHARMACEUTICALS, INC. | Yvonne L. Greenstreet | $14.9M | 2025 |
| Alpha Cognition Inc. | Lauren D'Angelo | $2.4M | 2025 |
| Altimmune, Inc. | Vipin K. Garg | $6.1M | 2024 |
| Alto Neuroscience, Inc. | Amit Etkin | $2.2M | 2025 |
| ALUMIS INC. | Martin Babler | $5.9M | 2025 |
| ALX ONCOLOGY HOLDINGS INC | Harish Shantharam | $1.7M | 2025 |
| Alzamend Neuro, Inc. | David J. Katzoff | $150K | 2025 |
| AMARIN CORP PLC\UK | Peter L. Fishman | $1M | 2025 |
| Amneal Pharmaceuticals, Inc. | Chintu Patel | $8.7M | 2025 |
| Amphastar Pharmaceuticals, Inc. | Jacob Liawatidewi | $2M | 2025 |
| Amylyx Pharmaceuticals, Inc. | Joshua Cohen | $2.7M | 2025 |
| AN2 Therapeutics, Inc. | Josh Eizen | $807K | 2025 |
| ANAPTYSBIO, INC | Paul Lizzul | $2.4M | 2025 |
| Anebulo Pharmaceuticals, Inc. | Richard Anthony Cunningham | $1.7M | 2024 |
| ANI PHARMACEUTICALS INC | Nikhil Lalwani | $10.3M | 2025 |
| Anixa Biosciences Inc | Michael J. Catelani | $1.3M | 2025 |
| Annexon, Inc. | Douglas Love | $3.6M | 2025 |
| Aprea Therapeutics, Inc. | John P. Hamill | $491K | 2025 |
| Aquestive Therapeutics, Inc. | Daniel Barber | $3.5M | 2025 |
| Arbutus Biopharma Corp | Lindsay Androski | $1.4M | 2025 |
| Arcturus Therapeutics Holdings Inc. | Dr. Padmanabh Chivukula | $862K | 2025 |
| Arcutis Biotherapeutics, Inc. | Todd Franklin Watanabe | $3.7M | 2024 |
| ARDELYX, INC. | Michael Raab | $7.8M | 2025 |
| Armata Pharmaceuticals, Inc. | Deborah Birx | $1.8M | 2024 |
| ArriVent BioPharma, Inc. | Zhengbin (Bing) Yao | $2.4M | 2024 |
| ARROWHEAD PHARMACEUTICALS, INC. | Christopher Anzalone | $12.4M | 2024 |
| ARS Pharmaceuticals, Inc. | Richard Lowenthal | $7.2M | 2024 |
| ARVINAS, INC. | Andrew Saik | $903K | 2025 |
| Aspira Women's Health Inc. | Michael Buhle | $420K | 2025 |
| ASSEMBLY BIOSCIENCES, INC. | Jason A. Okazaki | $1.8M | 2024 |
| Atea Pharmaceuticals, Inc. | Jean-Pierre Sommadossi | $4.2M | 2024 |
| ATOSSA THERAPEUTICS, INC. | Mark J. Daniel | $536K | 2025 |
| Aura Biosciences, Inc. | Elisabet de los Pinos | $4M | 2025 |
| Aurinia Pharmaceuticals Inc. | Joseph Miller | $2.1M | 2025 |
| Avalo Therapeutics, Inc. | Garry Neil | $3.8M | 2025 |
| Azitra, Inc. | Norman Staskey | $497K | 2025 |
| Bausch Health Companies Inc. | Thomas J. Appio | $16.9M | 2025 |
| Beam Therapeutics Inc. | Sravan K. Emany | $1.3M | 2025 |
| Benitec Biopharma Inc. | Megan Boston | $3.2M | 2026 |
| BeOne Medicines Ltd. | Dr. Lai Wang | $18.3M | 2025 |
| BetterLife Pharma Inc. | Ahmad Doroudian | $861K | 2018 |
| Bicara Therapeutics Inc. | Claire Mazumdar | $928K | 2025 |
| BIO-TECHNE Corp | Kim Kelderman | $8.2M | 2025 |
| BioAge Labs, Inc. | Kristen Fortney | $2.9M | 2025 |
| BioAtla, Inc. | Richard A. Waldron | $516K | 2025 |
| BioCardia, Inc. | David McClung | $355K | 2024 |
| BIOCRYST PHARMACEUTICALS INC | Jon P. Stonehouse | $13M | 2025 |
| Biofrontera Inc. | Fred Leffler | $554K | 2025 |
| BIOGEN INC. | Christopher A. Viehbacher | $23.6M | 2025 |
| BIOMARIN PHARMACEUTICAL INC | Alexander Hardy | $21.9M | 2025 |
| Biomea Fusion, Inc. | Michael J.M. Hitchcock | $2.6M | 2025 |
| BIOMERICA INC | Allen Barbieri | $165K | 2026 |
| BIOVIE INC. | Cuong Do | $1.4M | 2026 |
| BioXcel Therapeutics, Inc. | Vimal Mehta | $1.1M | 2024 |
| Black Diamond Therapeutics, Inc. | Mark A. Velleca | $2.2M | 2025 |
| Bolt Biotherapeutics, Inc. | Grant Yonehiro | $4M | 2025 |
| Boundless Bio, Inc. | Zachary D. Hornby | $6.1M | 2024 |
| BRAINSTORM CELL THERAPEUTICS INC. | Chaim Lebovits (*) | $750K | 2024 |
| BriaCell Therapeutics Corp. | Dr. William V. Williams | $781K | 2025 |
| BridgeBio Oncology Therapeutics, Inc. | Eli Wallace | $11.5M | 2025 |
| BridgeBio Pharma, Inc. | Neil Kumar | $14.9M | 2025 |
| BRISTOL MYERS SQUIBB CO | Christopher S. Boerner | $21.9M | 2025 |
| BullFrog AI Holdings, Inc. | Josh Blacher | $254K | 2025 |
| C4 Therapeutics, Inc. | Kendra R. Adams | $1.5M | 2025 |
| Cabaletta Bio, Inc. | Steven Nichtberger | $8.1M | 2024 |
| Cadrenal Therapeutics, Inc. | Matthew Szot | $1.3M | 2025 |
| CalciMedica, Inc. | A. Rachel Leheny | $1.7M | 2024 |
| Calidi Biotherapeutics, Inc. | Andrew Jackson | $594K | 2025 |
| Camp4 Therapeutics Corp | Kelly Gold | $1.8M | 2025 |
| Candel Therapeutics, Inc. | Paul Peter Tak | $5.3M | 2025 |
| Canopy Growth Corp | Luc | $3.6M | 2026 |
| Cardio Diagnostics Holdings, Inc. | Warren Hosseinion | $300K | 2025 |
| Caribou Biosciences, Inc. | Rachel Haurwitz | $4.2M | 2024 |
| Cartesian Therapeutics, Inc. | Blaine Davis | $1.9M | 2025 |
| CDT Equity Inc. | James Bligh | $1.5M | 2025 |
| Celldex Therapeutics, Inc. | Anthony S. Marucci | $5.4M | 2025 |
| Cellectar Biosciences, Inc. | James V. Caruso | $3M | 2024 |
| Celularity Inc | Robert J. Hariri | $1.2M | 2023 |
| Century Therapeutics, Inc. | Gregory Russotti | $912K | 2025 |
| CervoMed Inc. | William Elder | $686K | 2025 |
| CG Oncology, Inc. | Arthur Kuan | $11.9M | 2025 |
| CHAMPIONS ONCOLOGY, INC. | David Miller | $388K | 2026 |
| Charlie's Holdings, Inc. | Matthew P. Montesano | $124K | 2025 |
| Chemomab Therapeutics Ltd. | Adi Mor | $519 | 2021 |
| CHINA PHARMA HOLDINGS, INC. | Zhilin Li | $242K | 2023 |
| Cingulate Inc. | Shane J. Schaffer | $770K | 2024 |
| CITIUS ONCOLOGY, INC. | Myron Holubiak | $2.2M | 2025 |
| Citius Pharmaceuticals, Inc. | Myron Holubiak | $2.5M | 2025 |
| Climb Bio, Inc. | Aoife Brennan | $6M | 2024 |
| CNS Pharmaceuticals, Inc. | John Climaco | $1.2M | 2025 |
| Cogent Biosciences, Inc. | Andrew Robbins | $27.8M | 2025 |
| COGNITION THERAPEUTICS INC | Lisa Ricciardi | $1.5M | 2025 |
| Coherus Oncology, Inc. | Bryan McMichael | $1.1M | 2025 |
| COLLEGIUM PHARMACEUTICAL, INC | Colleen Tupper | $3.5M | 2025 |
| COMPASS Pathways plc | Guy Goodwin | $909K | 2025 |
| Compass Therapeutics, Inc. | Thomas J. Schuetz | $5.1M | 2025 |
| Context Therapeutics Inc. | Martin Lehr | $1.5M | 2025 |
| Contineum Therapeutics, Inc. | Peter T. Slover | $1.6M | 2025 |
| Corbus Pharmaceuticals Holdings, Inc. | Sean Moran | $1.8M | 2025 |
| CORCEPT THERAPEUTICS INC | Atabak Mokari | $6.1M | 2025 |
| CorMedix Inc. | Elizabeth Hurlburt | $3.7M | 2025 |
| Corvus Pharmaceuticals, Inc. | Leiv Lea | $3.2M | 2025 |
| Coya Therapeutics, Inc. | Howard Berman | $1.5M | 2025 |
| CRISPR Therapeutics AG | Samarth Kulkarni | $33.2M | 2024 |
| Cronos Group Inc. | Anna Shlimak | $1.2M | 2025 |
| Cryoport, Inc. | Jerrell W. Shelton | $2.4M | 2025 |
| Cullinan Therapeutics, Inc. | Nadim Ahmed | $7.7M | 2024 |
| CV Sciences, Inc. | Joerg Grasser | $308K | 2025 |
| CYPHERPUNK TECHNOLOGIES INC. | Douglas E. Onsi | $4.7M | 2025 |
| CytoDyn Inc. | Robert E. Hoffman | $1.9M | 2026 |
| CYTOKINETICS INC | Robert I. Blum | $11.9M | 2025 |
| Damora Therapeutics, Inc. | Former President and | $1.3M | 2025 |
| DBV Technologies S.A. | Virginie Boucinha | $1.1M | 2025 |
| Definium Therapeutics, Inc. | Brandi L. Roberts | $5.1M | 2025 |
| Denali Therapeutics Inc. | Ryan J. Watts | $6.6M | 2024 |
| Dermata Therapeutics, Inc. | Kyri K. Van Hoose | $509K | 2025 |
| Design Therapeutics, Inc. | Pratik Shah | $790K | 2024 |
| DiaMedica Therapeutics Inc. | Rick Pauls | $1.6M | 2024 |
| Dianthus Therapeutics, Inc. /DE/ | Ryan Savitz | $5.1M | 2025 |
| Disc Medicine, Inc. | Jean Franchi | $4.2M | 2025 |
| Dogwood Therapeutics, Inc. | Greg Duncan | $881K | 2024 |
| DYADIC INTERNATIONAL INC | Joseph Hazelton | $483K | 2025 |
| Dyne Therapeutics, Inc. | Erick Lucera | $2.7M | 2025 |
| Edesa Biotech, Inc. | Peter Weiler | $265K | 2025 |
| Edgewise Therapeutics, Inc. | Kevin Koch | $7.6M | 2024 |
| Editas Medicine, Inc. | Gilmore O'Neill | $5.1M | 2024 |
| Elanco Animal Health Inc | Jeffrey Simmons | $14.9M | 2025 |
| Eledon Pharmaceuticals, Inc. | Paul Little | $1.6M | 2025 |
| Elicio Therapeutics, Inc. | Robert Connelly | $1.9M | 2025 |
| Eloxx Pharmaceuticals, Inc. | Daniel E. Geffken | $64K | 2022 |
| ELUTIA INC. | Matthew Ferguson | $747K | 2025 |
| Emergent BioSolutions Inc. | Joseph Papa | $5.3M | 2025 |
| Emmaus Life Sciences, Inc. | Yutaka Niihara | $385K | 2020 |
| ENANTA PHARMACEUTICALS INC | Jay R. Luly | $2.7M | 2024 |
| enGene Therapeutics Inc. | Hussein Sweiti | $3.2M | 2025 |
| Enliven Therapeutics, Inc. | Named Executive Officers | $11.9M | 2025 |
| Ensysce Biosciences, Inc. | Dave Humphrey | $371K | 2024 |
| Entera Bio Ltd. | Hillel Galitzer | $531 | 2025 |
| Entrada Therapeutics, Inc. | Natarajan Sethuraman Ph. D. | $2.3M | 2025 |
| Enveric Biosciences, Inc. | Joseph Tucker | $612K | 2024 |
| Equillium, Inc. | Christine Zedelmayer | $2.1M | 2025 |
| Erasca, Inc. | Jonathan E. Lim | $3.9M | 2024 |
| Eton Pharmaceuticals, Inc. | James R. Gruber | $1.4M | 2025 |
| Evofem Biosciences, Inc. | Ivy Zhang | $695K | 2024 |
| Evolus, Inc. | Tatjana Mitchell | $3.2M | 2025 |
| Evommune, Inc. | Gregory S. Moss | $4.6M | 2025 |
| EXELIXIS, INC. | Michael M. Morrissey | $12.7M | 2024 |
| EXICURE, INC. | Andy Yoo | $27K | 2024 |
| FATE THERAPEUTICS INC | Bahram Valamehr | $3.6M | 2024 |
| FENNEC PHARMACEUTICALS INC. | Jeffrey Hackman | $1.6M | 2024 |
| FILANA THERAPEUTICS, INC. | R. Christopher Cook | $819K | 2025 |
| FITLIFE BRANDS, INC. | Ryan Hansen | $347K | 2025 |
| Foghorn Therapeutics Inc. | Steven Bellon | $1.2M | 2025 |
| Fulcrum Therapeutics, Inc. | Alan Musso | $1.8M | 2025 |
| Gain Therapeutics, Inc. | Gianluca Fuggetta | $345K | 2025 |
| GENELUX Corp | Matthew Pulisic | $1.5M | 2025 |
| Genprex, Inc. | Mark S. Berger | $689K | 2025 |
| GERON CORP | John A. Scarlett | $7.4M | 2025 |
| GILEAD SCIENCES, INC. | Daniel P. O'Day | $28.4M | 2025 |
| Ginkgo Bioworks Holdings, Inc. | Reshma Shetty | $3.5M | 2025 |
| Grace Therapeutics, Inc. | Prashant Kohli | $1.3M | 2026 |
| Greenwich LifeSciences, Inc. | Snehal Patel | $6M | 2025 |
| GRI Bio, Inc. | Leanne Kelly | $585K | 2025 |
| GYRE THERAPEUTICS, INC. | Ping Zhang | $4.1M | 2025 |
| HALOZYME THERAPEUTICS, INC. | Nicole LaBrosse | $4.6M | 2025 |
| Harmony Biosciences Holdings, Inc. | Jeffrey M. Dayno | $7.1M | 2024 |
| HARROW, INC. | Mark L. Baum | $23.6M | 2025 |
| Hepion Pharmaceuticals, Inc. | John Brancaccio | $198K | 2025 |
| HERON THERAPEUTICS, INC. /DE/ | Ira Duarte | $1.6M | 2025 |
| Humacyte, Inc. | Dale A. Sander | $2.1M | 2025 |
| IDEAYA Biosciences, Inc. | Yujiro S. Hata | $16.9M | 2024 |
| IDEXX LABORATORIES INC /DE | Jonathan J. Mazelsky | $14.6M | 2025 |
| ImageneBio, Inc. | Kristin Yarema | $8.2M | 2025 |
| Immix Biopharma, Inc. | Gabriel Morris | $1.4M | 2025 |
| IMMUCELL CORP /DE/ | Michael F. Brigham | $831K | 2025 |
| Immuneering Corp | Benjamin J. Zeskind | $1.9M | 2024 |
| ImmunityBio, Inc. | David Sachs | $4.2M | 2025 |
| Immunocore Holdings plc | Bahija Jallal | $10.9M | 2025 |
| Immunovant, Inc. | Eric Venker | $20.2M | 2026 |
| IMPACT BIOMEDICAL INC. | Frank D. Heuszel | $55K | 2024 |
| Imunon, Inc. | Michael Tardugno | $606K | 2025 |
| IN8BIO, INC. | William Ho | $1.5M | 2024 |
| Incannex Healthcare Inc. | Joseph Swan | $201K | 2025 |
| Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | $1.2M | 2024 |
| Inhibikase Therapeutics, Inc. | Milton H. Werner | $8M | 2024 |
| Inhibitor Therapeutics, Inc. | James A. McNulty | $363K | 2025 |
| Inhibrx Biosciences, Inc. | Mark P. Lappe | $4.7M | 2024 |
| Innoviva, Inc. | Stephen Basso | $2.2M | 2025 |
| INOVIO PHARMACEUTICALS, INC. | Jacqueline E. Shea | $1.6M | 2025 |
| Insight Molecular Diagnostics Inc. | Andrea James | $1.7M | 2025 |
| INSMED Inc | William H. Lewis | $14.5M | 2025 |
| Instil Bio, Inc. | Sandeep Laumas | $1.2M | 2025 |
| INTEGRATED BIOPHARMA INC | Dina Masi | $335K | 2025 |
| Intellia Therapeutics, Inc. | Edward J. Dulac III | $2.2M | 2025 |
| INTENSITY THERAPEUTICS, INC. | Joseph Talamo | $724K | 2025 |
| IRONWOOD PHARMACEUTICALS INC | Thomas McCourt | $1.9M | 2025 |
| IRulya Therapeutics Inc. | Brendan Hannah | $1.3M | 2025 |
| Jade Biosciences, Inc. | Tom Frohlich | $9.8M | 2025 |
| Janux Therapeutics, Inc. | David Campbell | $9M | 2024 |
| Jazz Pharmaceuticals plc | Renee D. Gala | $19.2M | 2025 |
| JOHNSON & JOHNSON | J. Duato | $32.8M | 2025 |
| Journey Medical Corp | Claude Maraoui | $1.7M | 2025 |
| JUPITER NEUROSCIENCES, INC. | Christer Rosén | $154K | 2024 |
| Jushi Holdings Inc. | James Cacioppo | $2.9M | 2025 |
| KALA BIO, Inc. | Todd Bazemore | $3.5M | 2025 |
| Kalaris Therapeutics, Inc. | Brett Hagen | $1.4M | 2025 |
| Karyopharm Therapeutics Inc. | Stuart Poulton | $1.4M | 2025 |
| Keros Therapeutics, Inc. | Jasbir Seehra | $2.5M | 2025 |
| Kiniksa Pharmaceuticals International, plc | Sanj K. Patel | $7M | 2024 |
| KIORA PHARMACEUTICALS INC | Brian M. Strem | $955K | 2024 |
| Korro Bio, Inc. | Ram Aiyar | $939K | 2024 |
| Krystal Biotech, Inc. | Kathryn A. Romano | $2.3M | 2025 |
| Kura Oncology, Inc. | Brian Powl | $2.7M | 2025 |
| Kymera Therapeutics, Inc. | Nello Mainolfi | $15.4M | 2024 |
| Kyverna Therapeutics, Inc. | Warner Biddle | $15M | 2024 |
| Lantern Pharma Inc. | David R. Margrave | $586K | 2025 |
| Lantheus Holdings, Inc. | Paul M. Blanchfield | $5.4M | 2025 |
| LB PHARMACEUTICALS INC | Anna Eramo | $2.4M | 2025 |
| LENZ Therapeutics, Inc. | Evert Schimmelpennink | $7M | 2025 |
| LeonaBio, Inc. | Mark Litton | $1.4M | 2025 |
| LEXICON PHARMACEUTICALS, INC. | Michael S. Exton | $2.8M | 2024 |
| LFTD PARTNERS INC. | Gerard M. Jacobs | $1M | 2022 |
| LianBio | Yizhe Wang | $19.5M | 2021 |
| Lifevantage Corp | Kristen Cunningham | $815K | 2026 |
| LIGAND PHARMACEUTICALS INC | Tavo Espinoza | $4.4M | 2025 |
| Liminatus Pharma, Inc. | Chris Kim | $183K | 2025 |
| Lineage Cell Therapeutics, Inc. | Jill A. Howe | $1M | 2025 |
| Lipocine Inc. | Mahesh V. Patel | $986K | 2025 |
| Liquidia Corp | Michael Kaseta | $4.2M | 2025 |
| LISATA THERAPEUTICS, INC. | David J. Mazzo | $1.1M | 2025 |
| Longeveron Inc. | Wa'el Hashad | $1.3M | 2025 |
| Lyell Immunopharma, Inc. | Lynn Seely | $4.2M | 2025 |
| MACROGENICS INC | Ezio Bonvini | $1.2M | 2025 |
| MADRIGAL PHARMACEUTICALS, INC. | Bill Sibold | $19.2M | 2025 |
| MAIA Biotechnology, Inc. | Vlad Vitoc | $2.1M | 2025 |
| MANNATECH INC | James Clavijo | $290K | 2025 |
| MANNKIND CORP | Christopher B. Prentiss | $2.9M | 2025 |
| MapLight Therapeutics, Inc. | Vishwas Setia | $6.2M | 2025 |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | William E. Martin III | $3.5M | 2025 |
| Marker Therapeutics, Inc. | Juan Vera | $400K | 2024 |
| Matinas BioPharma Holdings, Inc. | James J. Ferguson | $590K | 2024 |
| Maze Therapeutics, Inc. | Jason Coloma | $5.8M | 2024 |
| MBX Biosciences, Inc. | Richard Bartram | $1.5M | 2025 |
| MEDICINOVA INC | Yuichi Iwaki | $1.4M | 2024 |
| MeiraGTx Holdings plc | Richard Giroux | $8.1M | 2025 |
| Merck & Co., Inc. | Robert M. Davis | $20.8M | 2025 |
| Mereo BioPharma Group plc | Charles Sermon | $1.2M | 2025 |
| Metagenomi Therapeutics, Inc. | Jian Irish | $3.8M | 2024 |
| MetaVia Inc. | Hyung Heon Kim | $756K | 2025 |
| Milestone Pharmaceuticals Inc. | David Bharucha | $1M | 2025 |
| Mineralys Therapeutics, Inc. | Adam Levy | $2.2M | 2025 |
| Minerva Neurosciences, Inc. | Geoffrey Race | $6.3M | 2025 |
| MiNK Therapeutics, Inc. | Christine M. Klaskin | $30K | 2025 |
| Moderna, Inc. | Stéphane Bancel | $19.9M | 2025 |
| Monopar Therapeutics | Quan Vu | $2.1M | 2025 |
| Monte Rosa Therapeutics, Inc. | Markus Warmuth | $2.4M | 2024 |
| MoonLake Immunotherapeutics | Dr. Jorge Santos da Silva | $4.9M | 2025 |
| MYRIAD GENETICS INC | Samraat S. Raha | $5.7M | 2025 |
| NATURAL ALTERNATIVES INTERNATIONAL INC | Mark A. LeDoux | $563K | 2025 |
| NATURES SUNSHINE PRODUCTS INC | Ken Romanzi | $3.9M | 2025 |
| NEKTAR THERAPEUTICS | Howard W. Robin | $6.3M | 2025 |
| NEOGEN CORP | Tamara A. Ranalli (⁷) | $2.1M | 2026 |
| Neumora Therapeutics, Inc. | Paul L. Berns | $8.6M | 2024 |
| NEUROCRINE BIOSCIENCES INC | Kyle W. Gano | $13.4M | 2025 |
| Neurogene Inc. | Christine Mikail | $2.8M | 2025 |
| NEUTRA CORP. | Christopher Brown | $31K | 2015 |
| NextCure, Inc. | Michael Richman | $942K | 2025 |
| Niagen Bioscience, Inc. | Robert Fried | $1.2M | 2024 |
| Nkarta, Inc. | Paul J. Hastings | $3M | 2025 |
| NORTHWEST BIOTHERAPEUTICS INC | Linda F. Powers | $1.2M | 2024 |
| NOVAVAX INC | John C. Jacobs | $8.9M | 2025 |
| NRX Pharmaceuticals, Inc. | Jonathan Javitt | $630K | 2023 |
| Nurix Therapeutics, Inc. | Arthur T. Sands | $6.4M | 2025 |
| Nuvectis Pharma, Inc. | Ron Bentsur | $2.6M | 2025 |
| Olema Pharmaceuticals, Inc. | Shane Kovacs | $1.9M | 2025 |
| OMEROS CORP | Gregory A. Demopulos | $4.2M | 2025 |
| ONCOLYTICS BIOTECH INC | Jared Kelly | $2.1M | 2025 |
| Onconetix, Inc. | Karina Fedasz (4); | $352K | 2025 |
| OnKure Therapeutics, Inc. | Nicholas A. Saccomano | $1.5M | 2025 |
| OPKO HEALTH, INC. | Steven D. Rubin | $1.6M | 2025 |
| Opus Genetics, Inc. | Dr. George Magrath | $1.5M | 2025 |
| ORAGENICS INC | Joseph Redmond | $198K | 2025 |
| Organogenesis Holdings Inc. | David Francisco | $2M | 2025 |
| Oric Pharmaceuticals, Inc. | Dominic Piscitelli | $2.2M | 2025 |
| Oruka Therapeutics, Inc. | Joana Goncalves | $2.3M | 2025 |
| OS Therapies Inc | Paul A. Romness | $1.7M | 2024 |
| Ovid Therapeutics Inc. | Margaret Alexander | $1M | 2025 |
| Pacira BioSciences, Inc. | Frank Lee | $15.9M | 2024 |
| PALATIN TECHNOLOGIES INC | Carl Spana | $1.4M | 2024 |
| PALISADE BIO, INC. | J.D. Finley | $813K | 2024 |
| PALVELLA THERAPEUTICS, INC. | Wesley H. Kaupinen | $3.4M | 2025 |
| Pasithea Therapeutics Corp. | Daniel Schneiderman | $895K | 2025 |
| Passage BIO, Inc. | Kathleen Borthwick | $852K | 2025 |
| PDS Biotechnology Corp | Frank Bedu-Addo | $828K | 2025 |
| Pelthos Therapeutics Inc. | Francis Knuettel II | $2.3M | 2025 |
| PepGen Inc. | James McArthur | $3.3M | 2025 |
| PERRIGO Co plc | Patrick Lockwood-Taylor | $9M | 2025 |
| Perspective Therapeutics, Inc. | Juan Graham | $2.2M | 2025 |
| PharmaCyte Biotech, Inc. | Carlos A. Trujillo | $482K | 2025 |
| Phathom Pharmaceuticals, Inc. | Terrie Curran | $3.6M | 2024 |
| PLIANT THERAPEUTICS, INC. | Bernard Coulie | $5.5M | 2025 |
| Pluri Inc. | Liat Zalts | $590K | 2025 |
| PMV Pharmaceuticals, Inc. | David H. Mack | $1.7M | 2025 |
| Polaryx Therapeutics, Inc. | Lisa Bollinger | $483K | 2025 |
| Praxis Precision Medicines, Inc. | Marcio Souza | $8.7M | 2025 |
| PRECIGEN, INC. | Helen Sabzevari | $5.4M | 2025 |
| PRECISION BIOSCIENCES INC | Michael Amoroso | $2.2M | 2025 |
| Prelude Therapeutics Inc | Krishna Vaddi | $2.3M | 2024 |
| Prime Medicine, Inc. | Allan Reine | $4.6M | 2024 |
| Processa Pharmaceuticals, Inc. | George Ng | $673K | 2025 |
| PROKIDNEY CORP. | Bruce Culleton | $3M | 2025 |
| Protagonist Therapeutics, Inc | Dinesh V. Patel | $12.9M | 2025 |
| Protalix BioTherapeutics, Inc. | Eyal Rubin | $832K | 2025 |
| Protara Therapeutics, Inc. | Jesse Shefferman | $1.8M | 2024 |
| PROTHENA CORP PUBLIC LTD CO | Tran B. Nguyen | $2.7M | 2025 |
| PROVECTUS BIOPHARMACEUTICALS, INC. | Edward Pershing | $2.1M | 2024 |
| PTC THERAPEUTICS, INC. | Pierre Gravier | $3.6M | 2025 |
| Pulmatrix, Inc. | Peter Ludlum | $510K | 2023 |
| PUMA BIOTECHNOLOGY, INC. | Maximo F. Nougues | $1.2M | 2025 |
| Q32 Bio Inc. | Lee Kalowski | $987K | 2025 |
| Quantum Cyber N.V. | William Caragol | $572K | 2025 |
| QuidelOrtho Corp | Brian J. Blaser | $11.3M | 2025 |
| Rafael Holdings, Inc. | William Conkling | $593K | 2025 |
| Rani Therapeutics Holdings, Inc. | Talat Imran | $1.1M | 2025 |
| Rapport Therapeutics, Inc. | Troy Ignelzi | $2.5M | 2025 |
| RECURSION PHARMACEUTICALS, INC. | Najat Khan | $5.3M | 2025 |
| REGENERON PHARMACEUTICALS, INC. | Leonard S. Schleifer | $6.8M | 2024 |
| REGENXBIO Inc. | Curran Simpson | $4.8M | 2024 |
| Rein Therapeutics, Inc. | Timothy M. Cunningham | $434K | 2025 |
| Relay Therapeutics, Inc. | Thomas Catinazzo | $1.6M | 2025 |
| RELMADA THERAPEUTICS, INC. | Maged Shenouda | $6.1M | 2025 |
| REPLIGEN CORP | Olivier Loeillot | $6.1M | 2025 |
| Replimune Group, Inc. | Sushil Patel | $5.8M | 2026 |
| REVELATION BIOSCIENCES, INC. | James Rolke | $813K | 2024 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Narayan Prabhu | $405K | 2024 |
| Revolution Medicines, Inc. | Jack Anders | $3.6M | 2025 |
| RHYTHM PHARMACEUTICALS, INC. | Hunter C. Smith | $6.2M | 2025 |
| Rocket One Inc. | Robb Knie | $1.2M | 2024 |
| ROCKET PHARMACEUTICALS, INC. | Gaurav D. Shah | $3.5M | 2025 |
| ROCKWELL MEDICAL, INC. | Jesse Neri | $829K | 2025 |
| Roivant Sciences Ltd. | Frank Torti | $123.3M | 2025 |
| Royalty Pharma plc | Pablo Legorreta | $938K | 2025 |
| Sagimet Biosciences Inc. | David Happel | $3.2M | 2025 |
| SANGAMO THERAPEUTICS, INC | Nathalie Dubois-Stringfellow | $1.1M | 2024 |
| Sarepta Therapeutics, Inc. | Cristin L. Rothfuss | $4.2M | 2025 |
| Savara Inc | Yasmine Wasfi | $2.6M | 2025 |
| Scholar Rock Holding Corp | David Hallal | $33.3M | 2025 |
| Schrodinger, Inc. | Ramy Farid | $4.1M | 2025 |
| Scienture Holdings, Inc. | Dr. Shankar Hariharan | $1.2M | 2025 |
| Scilex Holding Co | Stephen Ma | $1.5M | 2025 |
| SCYNEXIS INC | David Angulo | $1.5M | 2025 |
| SELLAS Life Sciences Group, Inc. | Angelos M. Stergiou | $1.9M | 2025 |
| Semnur Pharmaceuticals, Inc. | Stephen Ma | $151K | 2025 |
| Senti Biosciences Holdings, Inc. | Timothy Lu | $1.7M | 2023 |
| Septerna, Inc. | Jeffrey Finer | $4.7M | 2024 |
| Seres Therapeutics, Inc. | Thomas J. DesRosier | $1.1M | 2025 |
| Shattuck Labs, Inc. | Taylor Schreiber | $3.2M | 2024 |
| SIGA TECHNOLOGIES INC | Diem Nguyen | $3.2M | 2025 |
| Silence Therapeutics plc | Rhonda Hellums | $1.2M | 2025 |
| Sionna Therapeutics, Inc. | Michael Cloonan | $3.7M | 2024 |
| Skye Bioscience, Inc. | Punit Dhillon | $1.4M | 2025 |
| Solid Biosciences Inc. | Alexander Cumbo | $4.9M | 2024 |
| Spero Therapeutics, Inc. | Tim Keutzer | $1.4M | 2025 |
| SPRUCE BIOSCIENCES, INC. | Samir Gharib | $1.5M | 2025 |
| Spyre Therapeutics, Inc. | Scott Burrows | $2.2M | 2025 |
| STANDARD BIOTOOLS INC. | Michael Egholm | $8.8M | 2025 |
| Stoke Therapeutics, Inc. | Ian F. Smith | $27M | 2025 |
| Structure Therapeutics Inc. | Raymond Stevens | $8.4M | 2025 |
| SUPERNUS PHARMACEUTICALS, INC. | Jack A. Khattar | $15.5M | 2025 |
| Surrozen, Inc./DE | Charles Williams | $1.5M | 2025 |
| Syndax Pharmaceuticals Inc | Keith A. Goldan | $2.5M | 2025 |
| Synergy CHC Corp. | Alfred Baumeler | $395K | 2025 |
| SYNLOGIC, INC. | Antoine Awad | $1.3M | 2024 |
| TALPHERA, INC. | Raffi Asadorian | $727K | 2025 |
| Tango Therapeutics, Inc. | Adam Crystal | $3.8M | 2024 |
| Tarsus Pharmaceuticals, Inc. | Jeffrey Farrow | $2.7M | 2025 |
| Taysha Gene Therapies, Inc. | Sean Nolan | $4.1M | 2025 |
| Tectonic Therapeutic, Inc. | Alise Reicin | $5.9M | 2024 |
| Telomir Pharmaceuticals, Inc. | Erez Aminov | $7.6M | 2024 |
| Tempest Therapeutics, Inc. | Samuel Whiting | $976K | 2025 |
| TENAX THERAPEUTICS, INC. | Stuart Rich | $3.7M | 2025 |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | Richard Francis | $19.2M | 2025 |
| TherapeuticsMD, Inc. | Joseph Ziegler | $120K | 2024 |
| Tilray Brands, Inc. | Irwin Simon | $22.2M | 2026 |
| Tonix Pharmaceuticals Holding Corp. | Jessica Morris | $1.2M | 2025 |
| Transcode Therapeutics, Inc. | Philippe P. Calais | $374K | 2025 |
| Travere Therapeutics, Inc. | Christopher Cline | $2.3M | 2025 |
| Trevi Therapeutics, Inc. | Jennifer Good | $2.6M | 2024 |
| TuHURA Biosciences, Inc./NV | Dan Dearborn | $1.8M | 2025 |
| Turn Therapeutics Inc. | Zuraiz Chaudhary | $1.4M | 2025 |
| Tvardi Therapeutics, Inc. | Ryan Maynard | $1.1M | 2025 |
| Twist Bioscience Corp | Emily M. Leproust | $13.8M | 2025 |
| Tyra Biosciences, Inc. | Todd Harris | $7.6M | 2024 |
| Ultragenyx Pharmaceutical Inc. | Emil D. Kakkis | $11.4M | 2025 |
| Unicycive Therapeutics, Inc. | Shalabh Gupta | $2.4M | 2024 |
| uniQure N.V. | Christian Klemt | $2.4M | 2025 |
| Upstream Bio, Inc. | E. Rand Sutherland | $9.1M | 2024 |
| UroGen Pharma Ltd. | Mark Schoenberg | $1.2M | 2025 |
| VACCINEX, INC. | Ernest S. Smith | $309K | 2023 |
| Vanda Pharmaceuticals Inc. | Mihael H. Polymeropoulos | $3.9M | 2025 |
| Vaxcyte, Inc. | Andrew Guggenhime | $6.1M | 2025 |
| Vera Therapeutics, Inc. | Marshall Fordyce | $7M | 2025 |
| Verastem, Inc. | Matthew Ros | $1.6M | 2025 |
| Vericel Corp | Joe Mara | $3.2M | 2025 |
| Verrica Pharmaceuticals Inc. | John J. Kirby | $615K | 2025 |
| VERTEX PHARMACEUTICALS INC / MA | Reshma Kewalramani | $21.5M | 2024 |
| VERU INC. | Mitchell S. Steiner | $1.6M | 2025 |
| Viatris Inc | Scott A. Smith | $15.3M | 2025 |
| Viking Therapeutics, Inc. | Marianne Mancini | $5.2M | 2025 |
| Vir Biotechnology, Inc. | Marianne De Backer | $7.8M | 2025 |
| Vireo Growth Inc. | John Mazarakis | $20M | 2025 |
| Viridian Therapeutics, Inc.\DE | Stephen Mahoney | $6.8M | 2025 |
| Viskase Holdings, Inc. | Richard L. Feinstein | $224K | 2023 |
| VOLITIONRX LTD | Dr. Gaetan Michel | $440K | 2025 |
| Vor Biopharma Inc. | Sandesh Mahatme | $39.4M | 2025 |
| Voyager Therapeutics, Inc. | Alfred Sandrock | $2.5M | 2025 |
| vTv Therapeutics Inc. | Michael Tung | $2.4M | 2025 |
| Wave Life Sciences, Inc. | Paul B. Bolno | $4.3M | 2024 |
| Werewolf Therapeutics, Inc. | Daniel J. Hicklin | $2.5M | 2024 |
| Whitehawk Therapeutics, Inc. | Scott Giacobello | $2.1M | 2025 |
| X4 Pharmaceuticals, Inc | Paula Ragan | $2.6M | 2025 |
| XBiotech Inc. | Sushma Shivaswamy | $658K | 2024 |
| Xencor Inc | Bassil I. Dahiyat | $6.8M | 2024 |
| Xenetic Biosciences, Inc. | Jeffrey F. Eisenberg | $673K | 2024 |
| Xenon Pharmaceuticals Inc. | Thomas Kelly | $7.2M | 2025 |
| Xeris Biopharma Holdings, Inc. | Steven M. Pieper | $1.9M | 2025 |
| Xilio Therapeutics, Inc. | Christopher Frankenfield | $3.2M | 2025 |
| Yarrow Bioscience, Inc. | David Domzalski | $2M | 2024 |
| Zai Lab Ltd | Yajing Chen | $3.2M | 2025 |
| Zenas BioPharma, Inc. | Leon O. Moulder | $4.7M | 2025 |
| Zentalis Pharmaceuticals, Inc. | Julie Eastland | $1.3M | 2025 |
| ZEVRA THERAPEUTICS, INC. | Neil F. McFarlane | $3.8M | 2025 |
| Zura Bio Ltd | Robert Lisicki | $1.7M | 2025 |
| Zymeworks Inc. | Kenneth Galbraith | $6.6M | 2025 |
| ZyVersa Therapeutics, Inc. | Peter Wolfe | $395K | 2024 |
Source: each company's latest definitive proxy statement (SEC Form DEF 14A), Summary Compensation Table. Figures are as reported. Snapshot as of 2026-10-28.